Gilead Sciences (GILD) Long-Term Deferred Tax (2009 - 2026)

Gilead Sciences (GILD) has reported Long-Term Deferred Tax for 12 consecutive years, with $2.5 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Long-Term Deferred Tax fell 8.6% year-over-year to $2.5 billion; the trailing twelve-month figure through Jun 2026 stood at $2.5 billion (down 8.6% YoY), and the FY2025 full-year result was $2.0 billion, down 17.41% from the prior year.
• Long-Term Deferred Tax grew to $2.5 billion in Q2 2026 per GILD's latest filing, from $1.8 billion in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $2.7 billion in Q2 2025 and bottomed at $1.8 billion in Q1 2026.
• Historically, Long-Term Deferred Tax has averaged $2.3 billion across 3 years, with a median of $2.4 billion in 2024.
• The widest YoY moves for Long-Term Deferred Tax: up 8.6% in 2026, down 31.3% in 2026.
• Over 3 years, Long-Term Deferred Tax stood at $2.4 billion in 2024, then dropped by 17.41% to $2.0 billion in 2025, then climbed by 26.63% to $2.5 billion in 2026.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $2.5 billion, $1.8 billion, and $2.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.